Citeline Podcasts
Episodes
Harness Therapeutics CEO Talks Somatic Expansion for Neurodegeneration
03 Feb 2025
Contributed by Lukas
Harness Therapeutics' CEO talked to In Vivo about the company's scientific strategy, and its plans for expansion and partnering in the neurodegenerati...
Scrip's Five Must-Know Things
03 Feb 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 January 2025. In this episode: biopharma VC fundraisin...
Datamonitor Healthcare Podcast: Epidemiology in the Age of Real World Data and AI
31 Jan 2025
Contributed by Lukas
Summer Colling and Emma Wille speak with epidemiologists Ridwaan Ibrahim and Lucia Rodriguez-Garcia about the recent ISPOR conference. Ridwaan and Luc...
Drug Fix: President Trump’s Policies Begin Changing The US FDA, Kennedy’s Hill Hearings
31 Jan 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the...
Scrip's Five Must-Know Things - 27 January 2025
27 Jan 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 January 2025. In this episode: semaglutide in 2027 Med...
Drug Fix: Concerns and Questions As Trump Administration Takes Control Of US FDA
24 Jan 2025
Contributed by Lukas
Pink Sheet reporter and editors try to answer some emerging questions about the US Food and Drug Administration now that President Donald Trump has ta...
Fauna Bio: Gleaning Therapeutic Insights From Animals
20 Jan 2025
Contributed by Lukas
In Vivo speaks with Ashley Zender, CEO of Fauna Bio, a company using AI to identify drug targets based on natural disease resistance in animals. The c...
Scrip's Five Must-Know Things - 20 January 2025
20 Jan 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 January 2025. In this episode: a look at JPM; J&J’s ...
A “Game Changer” For The High-Risk MDS Patient Population
17 Jan 2025
Contributed by Lukas
Juho Jalkanen, CEO of Faron Pharma, discusses the importance of addressing unmet medical needs in cancer through breaking treatment resistance and dev...
Drug Fix: US FDA And Trump’s Reforms, CDER Director Parting Comments, 2024 Approval Trends
17 Jan 2025
Contributed by Lukas
Pink Sheet editors consider ex-FDA officials’ advice for the Trump Administration on implementing FDA reforms (:24), comments CDER Director Patrizia...
Scrip's Five Must-Know Things - 14 January 2025
14 Jan 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 January 2025. In this episode: key themes for JPM; 202...
Drug Fix: CDER Director Retires, US FDA Guidance ‘Blizzard,’ Rare Pediatric Disease Program Hangs On
10 Jan 2025
Contributed by Lukas
Pink Sheet editors discuss Center for Drug Evaluation and Research Director Patrizia Cavazzoni’s surprising retirement announcement (:32), the impor...
2025년 JP모건 헬스케어 컨퍼런스의 주요 주제는? (Korean-language podcast)
09 Jan 2025
Contributed by Lukas
트럼프 대통령의 취임 직전 열리는 2025년 JP모건 헬스케어 컨퍼런스에서 라이센스딜 및 M&A 뿐 아니라 미국 정치와...
Pre-JPM Biotech Dealmaking Roundtable
07 Jan 2025
Contributed by Lukas
As we enter 2025, In Vivo convened a group of biotech executives for a wide-ranging conversation about dealmaking this year and the challenges and opp...
Digital Health Roundup: 2025 Will See More AI/GenAI Adoption In Medtech, FDA’s Digital Health Push
06 Jan 2025
Contributed by Lukas
In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb brings highlights from Deloitte’s 2025 Life Sciences Outlook Report with me...
The Future of Immunotherapy
06 Jan 2025
Contributed by Lukas
In this episode of the In Vivo podcast, Harvard immunologist and co-founder of early-stage biotech Corner Therapeutics, Jonathan Kagan, talks about ha...
An Insight into NASH
31 Dec 2024
Contributed by Lukas
Emma and Summer meet with Datamonitor Healthcare analyst Ken Hoang, to discuss the non-alcoholic steatohepatitis (NASH) treatment market
올해의 Top 5 글로벌 제약 뉴스 (Korean language podcast) - 27 December 2024
27 Dec 2024
Contributed by Lukas
Scrip이 선정한 2024년의 Top 5 글로벌 제약바이오 뉴스입니다. https://insights.citeline.com/scrip/business/deals/the-top-five-pharma-...
Scrip's Five Must-Know Things - 23 December 2024
23 Dec 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 20 December 2024. In this episode: Pfizer’s 2025 policy...
The Future Of eClinical Technology
19 Dec 2024
Contributed by Lukas
The Future Of eClinical Technology by Citeline
The Generics Bulletin Podcast: Highlights Of 2024
16 Dec 2024
Contributed by Lukas
Generics Bulletin's editorial team discusses key topics from the year, including the latest rankings of the GB Top 50, Amgen's surprise launch of a US...
Five Must-Know Things - 16 December 2024
16 Dec 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 13 December 2024. In this episode: a snapshot of the atop...
The Role of Site Networks & Why They Matter
10 Dec 2024
Contributed by Lukas
Learn how utilizing a site network can improve clinical trial efficiency and scalability, data quality, patient access and recruitment, resource optim...
Datamonitor Healthcare Podcast: Psychedelic Symposium at the University of Wisconsin-Madison
10 Dec 2024
Contributed by Lukas
Summer Colling speaks with Emma Wille about the Psychedelic Symposium at the University of Wisconsin-Madison and what the future of psychedelic therap...
Scrip's Five Must-Know Things - 10 December 2024
10 Dec 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 December 2024. In this episode: Zepbound bests Wegovy; ...
Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases
09 Dec 2024
Contributed by Lukas
In this episode of the In Vivo podcast, Peter Flynn, CEO of Arialys Therapeutics, discusses the exciting field of autoimmune neuropsychiatry and the c...
Drug Fix: COVID-19 Vaccine EUAs In Danger, DOGE And US FDA, New 340B Rebate Pricing Models
06 Dec 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss potential threats to the COVID-19 vaccine pediatric indications under the Trump Administration (:24), the DOGE...
November 2024 Datamonitor Healthcare Podcast: Bispecific Antibodies in Oncology
05 Dec 2024
Contributed by Lukas
Emma and Summer meet with oncology analysts Neha Anand and David Dahan, to discuss an emerging class of drugs: bispecific antibodies.
Treating Rare Diseases With tRNA
04 Dec 2024
Contributed by Lukas
In this episode of the In Vivo podcast, Michelle Werner, CEO of Alltrna, discusses using tRNA as a therapeutic modality for rare diseases, including t...
Conference Catch-Up: BIO-Europe 2024
03 Dec 2024
Contributed by Lukas
Biopharma is evolving through collaboration, early-phase deal-making and innovation in precision medicine and AI. At BIO-Europe, Norstella's subject...
Scrip's Five Must-Know Things - 2 December 2024
02 Dec 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 29 November 2024. In this episode: Marks on Trump’s thr...
Scrip Awards Podcast, Ep2: 2024 Awards Preview & Verona Pharma Interview
28 Nov 2024
Contributed by Lukas
A preview of the 2024 Scrip Awards and an interview with last year’s Executive of the Year, David Zaccardelli, CEO of Verona Pharma.
Scrip's Five Must-Know Things - 25 November 2024
22 Nov 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 22 November 2024. In this episode: Novo’s semaglutide l...
Drug Fix: Trump’s Potential Impact On FDA User Fees, Dr. Oz’s Potential Impact On CMS
22 Nov 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss concerns that the incoming administration could try to influence the upcoming FDA user fee reauthorization (:3...
Scrip's Five Must-Know Things - 18 November 2024
18 Nov 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 15 November 2024. In this episode: muscling into the obes...
Drug Fix: Trump Picks Robert F. Kennedy Jr. To Lead HHS, How Could He Disrupt FDA?
15 Nov 2024
Contributed by Lukas
Pink Sheet reporter and editors, and guest Michael McCaughan of Prevision Policy, continue the discussion of Donald Trump’s potential impact on the ...
Scrip M&A Podcast: Why Did Biopharma M&A Metrics Decline During Q2 And Q3
14 Nov 2024
Contributed by Lukas
Scrip senior writer Joseph Haas discusses recent merger-and-acquisition activity in the biopharma sector with Gerardo Ubaghs, CFO of Frontier Medicine...
Using AI To Predict Our Immune Responses
11 Nov 2024
Contributed by Lukas
In the latest episode of the In Vivo podcast, Noam Solomon, co-founder and CEO of Israeli-American biotech Immunai explains how his company is mapping...
Scrip's Five Must-Know Things - 11 November 2024
11 Nov 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 8 November 2024. In this episode: what Trump might mean f...
Conference Catch-Up: Navigating the Evolving CDMO Landscape
10 Nov 2024
Contributed by Lukas
Contract development and manufacturing organizations (CDMOs) are reshaping pharmaceutical production, playing a pivotal role in supply chain stability...
Drug Fix: How Will Trump’s Second Term Impact The US FDA?
08 Nov 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss potential changes that the incoming Trump Administration could make on the FDA, as well as worries about polit...
Digital Health Roundup: GE HealthCare On AI At HLTH; EU AI Act, Click Therapeutics
07 Nov 2024
Contributed by Lukas
In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb talks about her interview with GE HealthCare’s chief AI officer Parminder B...
Scrip's Five Must-Know Things - 5 November 2024
05 Nov 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 1 November 2024. In this episode: Lilly plans DTC tirzepa...
【3分で解説 世界のファーマ】第22回 AD治療、費用対効果に悩む英国 (Japanese-language podcast)
29 Oct 2024
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Scrip's Five Must-Know Things - 28 October 2024
28 Oct 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 October 2024. In this episode: Merck & Co’s Modifi a...
Conference Catch-Up: The Rise of Digital Therapeutics (Part 2)
26 Oct 2024
Contributed by Lukas
Health technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving treatments to patients. In parti...
October 2024 Datamonitor Healthcare Podcast: Insights from ESMO
21 Oct 2024
Contributed by Lukas
Emma and Summer meet with oncology analysts Neha Anand, Anna Simmons, and Nkiru Ibeanu, to share insights from the European Society of Medical Oncolog...
Scrip's Five Must-Know Things - 21 October 2024
21 Oct 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 October 2024. In this episode: J&J looks to Tremfya as...
Drug Fix: SubQ Drugs And Price Negotiations, GLP-1s In Court, US FDA Approach To Black Box AI
18 Oct 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss an emerging pharma strategy to avoid Medicare price negotiations (:25), legal wrangling related to compounding...
빅파마가 직면한 세포유전자 치료제 시장의 현실 (Korean-language podcast)
17 Oct 2024
Contributed by Lukas
빅파마들은 세포유전자 치료제를 출시하면서 이러한 치료의 비용과 복잡성이라는 현실적인 문제에 직면해 있습니...
China Biopharma Podcast - 16 October 2024 (Chinese language)
16 Oct 2024
Contributed by Lukas
Dexter Yan回顾了他在国庆长假前和阿斯利康全球执行副总裁-生物制药研发负责人Sharon Barr的采访。此外，本期播客迎...
Scrip's Five Must-Know Things - 15 October 2024
15 Oct 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 October 2024. In this episode: making cell and gene th...
Drug Fix: Inside Medicare Price Negotiations, New US FDA Vaccine Pathway
11 Oct 2024
Contributed by Lukas
Introduction: Pink Sheet reporter and editors discuss experts’ experience helping drug sponsors negotiate prices with CMS (:33) and the FDA’s prop...
Q&A Session on Psoriasis in Pediatric Patients with Dr. Valerie Welch
11 Oct 2024
Contributed by Lukas
Join us for a discussion on pediatric psoriasis and the importance of collaboration across specialties to improve treatment outcomes.
COPD Treatment Strategies: Q&A with Dr. Kenneth Chinsky
11 Oct 2024
Contributed by Lukas
Join us for a discussion on COPD and inhaler choice.
Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies
08 Oct 2024
Contributed by Lukas
Richard Lowenthal, co-founder, and CEO of ARS Pharma, highlights the crucial unmet need for needle-free injections. Challenging issues posed by curren...
Alpha-Synuclein Testing Comes of Age
04 Oct 2024
Contributed by Lukas
In the latest episode of the In Vivo podcast, Russ Lebovitz, the co-founder and scientist behind Amprion, a diagnostics company, discusses the role of...
Q&A Session: PIK3CA Mutations and Breast Cancer
03 Oct 2024
Contributed by Lukas
Join us for an informative discussion about PIK3CA testing and treatment with Dr. Neil Iyengar
Conference Catch-Up: LSX World Congress USA 2024
02 Oct 2024
Contributed by Lukas
Discover the game-changing insights from the LSX World Congress USA! Join Janelle Hart, Managing Editor at Citeline, a Norstella Company, as she expl...
The Future Of Drug R&D Is Self-Driving
30 Sep 2024
Contributed by Lukas
In the latest episode of the In Vivo podcast, Alan Aspuru-Guzik, a pioneer in chemical engineering who holds many positions, talks about how he is fol...
Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO
27 Sep 2024
Contributed by Lukas
Pink Sheet reporters and editors discuss Pfizer’s abrupt decision to withdraw Oxbryta (:32), the US FDA’s Oncologic Drugs Advisory Committee bring...
Challenges in the Development and Manufacturing of ADCs
24 Sep 2024
Contributed by Lukas
In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Gro...
September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up
19 Sep 2024
Contributed by Lukas
Emma Wille chats with oncology team director Dana Gheorghe, PhD, about the resurgence of radiopharmaceutical therapies in oncology. Other platforms (...
Health-Related Quality of Life Considerations In Clinical Trials
16 Sep 2024
Contributed by Lukas
In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affair...
Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care
13 Sep 2024
Contributed by Lukas
In this episode, HBW chats with Neil D’Souza, CEO of Makersite GmbH, a Stuttgart, Germany-based data software company that offers product data manag...
Drug Fix: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging
13 Sep 2024
Contributed by Lukas
Introduction: Pink Sheet reporter and editor discuss the FDA’s latest advertising enforcement letter, which targeted a migraine treatment TV commerc...
September 2024 Datamonitor Healthcare Podcast: Diving into the TME
13 Sep 2024
Contributed by Lukas
Emma and Summer meet with oncology analyst Flora to discuss the therapeutic potential of exploring the tumor microenvironment. Apple Podcasts - h...
The Generics Bulletin Podcast: Recent And Upcoming Industry Events
12 Sep 2024
Contributed by Lukas
Generics Bulletin's editorial team discusses recent conferences held by Medicines for Europe and the AAM, while looking ahead to the key off-patent in...
【3分で解説 世界のファーマ】第21回 中国企業 日本で続々治験開始へ (Japanese-language podcast)
10 Sep 2024
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
J&J, '차별화된' 비만 자산에 관심있어 (Korean-language podcast)
09 Sep 2024
Contributed by Lukas
호아킨 두아토 존슨앤존슨 대표가 모건스탠리 헬스케어 컨퍼런스에서 발표한 내용입니다. https://scrip.citeline.com/SC...
Scrip's Five Must-Know Things - 9 September 2024
09 Sep 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 September 2024. In this episode: J&J interested in diff...
Drug Fix: Pediatric Rare Disease PRV Deadline Approaches, Potential Makena Compounding Ban
06 Sep 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss the potential fallout if the US FDA’s rare pediatric disease priority review voucher program is allowed to s...
Scrip's Five Must-Know Things - 2 September 2024
02 Sep 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 August 2024. In this episode: summer ADC dealmaking co...
Drug Fix: New US FDA Developments In AI Regulation
30 Aug 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, includ...
Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Gaming; DHCoE On AI; Hello Heart
29 Aug 2024
Contributed by Lukas
In this week’s Digital Health Roundup, Medtech Insight’s Ryan Nelson highlights Click Therapeutics’ FDA-cleared digital therapeutics (DTx) for d...
Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland
27 Aug 2024
Contributed by Lukas
Interest in the human gut microbiome and the influence it exerts on a person’s wellbeing, from cognitive health to immunity, has been rapidly increa...
Scrip's Five Must-Know Things - 26 August 2024
26 Aug 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 August 2024. In this episode: CMS’s price reveal bet...
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
22 Aug 2024
Contributed by Lukas
Following the recent FDA rejection of MDMA therapy for PTSD, Emma and Flora discuss the future role of psychedelics in the treatment of mental health ...
Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
19 Aug 2024
Contributed by Lukas
Keith Murphy, co-founder of Organovo, discusses the growing potential of bioprinting and how the company is using its technologies to study and develo...
Scrip's Five Must-Know Things - 19 August 2024
19 Aug 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into C...
Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices
16 Aug 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains...
【3分で解説 世界のファーマ】第20回 欧州心臓病学会 注目の新薬候補は (Japanese-language podcast)
15 Aug 2024
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge
14 Aug 2024
Contributed by Lukas
Compliance with environmental sustainability goals is no longer optional for medtech companies serving global healthcare markets. Thermo Fisher has ma...
Scrip's Five Must-Know Things - 13 August 2024
13 Aug 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 August 2024. In this episode: Amgen positions for obesi...
Why Purpose Is Key To Driving CHC Growth, With Haleon’s Bas Vorsteveld
12 Aug 2024
Contributed by Lukas
Since becoming a standalone consumer health company, Haleon has been driving awareness of public health issues such as chronic pain and children’s o...
Drug Fix: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms
09 Aug 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss former Surgeon General Jerome Adams’ views on how the FDA can better ensure clinical trial diversity (:27), ...
Type 2 Diabetes and SGLT2 Inhibitors Q&A
09 Aug 2024
Contributed by Lukas
In this audio, Dr. Anthony Fritz discusses Type 2 diabetes and the benefits of SGLT2 inhibitors. Learn how this treatment option can improve diabetes ...
비만치료제, 2024년 상반기 대형주를 지배하다 (Korean-language podcast)
07 Aug 2024
Contributed by Lukas
올해 상반기 일라이 릴리와 노보 노디스크의 주가가 가장 높은 상승세를 보인 반면, BMS와 길리어드의 주가는 가장...
Scrip's Five Must-Know Things - 5 August 2024
05 Aug 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 August 2024. In this episode: Pfizer bullish on its ora...
Drug Fix: August User Fee Goals, Oncology Trial Design Issues, EMA Review Changes
02 Aug 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss the US FDA drug approval decisions that could arrive in August (:34), a trial design issue that could ensnare ...
China Biotech Podcast - 2 August 2024 (Chinese language)
02 Aug 2024
Contributed by Lukas
RNK Pharma founder and CEO Yaning Wang joins Brian Yang to discuss Shanghai's latest biopharma stimulus policies and the globalization of China biotec...
July 2024 Datamonitor Healthcare Podcast: The Future of Biologics in COPD
31 Jul 2024
Contributed by Lukas
COPD expert Wen-Yu discusses what the entrance of biologics might mean for the COPD treatment landscape and shares a sneak peek from her upcoming pati...
Q&A Session on the Treatment of Multiple Myeloma
29 Jul 2024
Contributed by Lukas
Join us for an insightful Q&A session on the treatment of multiple myeloma with Oncologist Dr. Joshua Richter. In this video, Dr. Richter shares his e...
How To Make An Impact With Your OTC Brand, With PA Consulting’s Rhea Patten
29 Jul 2024
Contributed by Lukas
Consumers are expecting more and more from health and wellness brands, PA Consulting’s latest Brand Impact Index shows. Consumer health brands that ...
Scrip's Five Must-Know Things - 29 July 2024
29 Jul 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 July 2024. In this episode: Narasimhan plays the long ...
Drug Fix: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push
26 Jul 2024
Contributed by Lukas
Editors from the Pink Sheet and Medtech Insight discuss the retirement of Jeff Shuren (:35), PBM executives again appearing unscathed after another Ca...
The Exciting Future of Heart Failure Management
26 Jul 2024
Contributed by Lukas
Join Victoria Bradley and Dr. Andrew Freeman as they discuss the latest advancements in heart failure treatment, from innovative therapies to the role...
Early Detection Key in COPD Management (Q&A with Brittany Little, NP)
26 Jul 2024
Contributed by Lukas
This Q&A session emphasizes early diagnosis of COPD for better lung function preservation and disease control. It explores COPD symptoms, diagnosis to...
Digital Health Roundup: Brain Talk; Medtronic’s Digital Tech Report OR; UK Guidance
23 Jul 2024
Contributed by Lukas
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights AI discussions at the HLTH Europe conference and an interview wit...
Scrip's Five Must-Know Things - 22 July 2024
22 Jul 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 July 2024. In this episode: J&J’s Spravato on track ...